ENTRY       D08217                      Drug
NAME        Mibefradil (INN)
FORMULA     C29H38FN3O3
EXACT_MASS  495.2897
MOL_WEIGHT  495.6287
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01573  Calcium channel T type blocker
            Metabolizing enzyme inhibitor
             DG01634  CYP1A2 inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
REMARK      Same as: C07222
            ATC code: C08CX01
            Chemical structure group: DG00328
EFFICACY    Vasodilator, Calcium channel blocker
TARGET      CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]
            CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]
  PATHWAY   hsa04010(775+776+778+779+8911+8912+8913)  MAPK signaling pathway
            hsa04020(775+776+778+779+8911+8912+8913)  Calcium signaling pathway
            hsa04260(775+776+778+779)  Cardiac muscle contraction
            hsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes
            hsa04270(775+776+778+779)  Vascular smooth muscle contraction
INTERACTION CYP inhibition: CYP3A [HSA:1576 1577 1551], CYP1A2 [HSA:1544], CYP2D6 [HSA:1565]
STR_MAP     map07036  Calcium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C08 CALCIUM CHANNEL BLOCKERS
               C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
                C08CX Other selective calcium channel blockers with mainly vascular effects
                 C08CX01 Mibefradil
                  D08217  Mibefradil (INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01573  Calcium channel T type blocker
                DG00328  Mibefradil
                 D08217  Mibefradil
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               DG00328  Mibefradil
                D08217  Mibefradil
              DG01645  CYP2D6 inhibitor
               DG00328  Mibefradil
                D08217  Mibefradil
              DG02852  CYP3A/CYP3A4 inhibitor
               DG00328  Mibefradil
                D08217  Mibefradil
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-T
                 D08217  Mibefradil (INN)
                CACNA1-L
                 D08217  Mibefradil (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08217
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01573  Calcium channel T type blocker
                DG00328  Mibefradil
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               DG00328  Mibefradil
              DG01645  CYP2D6 inhibitor
               DG00328  Mibefradil
              DG02852  CYP3A/CYP3A4 inhibitor
               DG00328  Mibefradil
DBLINKS     CAS: 116644-53-2
            PubChem: 96024905
            ChEBI: 6920
            PDB-CCD: MWV
            LigandBox: D08217
            NIKKAJI: J281.718G
ATOM        36
            1   C1z C    20.8600  -17.0800
            2   C1y C    19.7400  -17.7100
            3   C1x C    20.8600  -15.7500
            4   C1b C    22.1200  -17.9200
            5   O7a O    23.1700  -14.8400
            6   C8y C    18.5500  -17.0100
            7   C1c C    19.6700  -19.0400
            8   C1x C    19.8100  -15.0500
            9   C1b C    23.3100  -17.2900
            10  C7a C    24.3600  -15.5400
            11  C8y C    18.5500  -15.6800
            12  C8x C    17.4300  -17.6400
            13  C1a C    18.4800  -19.6700
            14  C1a C    20.7900  -19.8100
            15  N1c N    24.4300  -17.9900
            16  C1b C    25.5500  -14.8400
            17  O6a O    24.3600  -16.9400
            18  C8x C    17.5000  -14.9800
            19  C8x C    16.2400  -16.9400
            20  C1b C    25.6200  -17.3600
            21  C1a C    24.4300  -19.3900
            22  O2a O    26.7400  -15.5400
            23  C8y C    16.2400  -15.6100
            24  C1b C    26.7400  -18.1300
            25  C1a C    27.9300  -14.8400
            26  X   F    15.1200  -14.9100
            27  C1b C    27.9300  -17.4300
            28  C8y C    29.1200  -18.2000
            29  N4x N    29.1200  -19.5300
            30  N5x N    30.3800  -17.7100
            31  C8y C    30.5200  -19.8100
            32  C8y C    31.2200  -18.6900
            33  C8x C    31.1500  -21.0000
            34  C8x C    32.5500  -18.6900
            35  C8x C    32.4800  -21.0000
            36  C8x C    33.1800  -19.9500
BOND        39
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     1   5 1 #Up
            5     2   6 1
            6     2   7 1 #Up
            7     3   8 1
            8     4   9 1
            9     5  10 1
            10    6  11 2
            11    6  12 1
            12    7  13 1
            13    7  14 1
            14    9  15 1
            15   10  16 1
            16   10  17 2
            17   11  18 1
            18   12  19 2
            19   15  20 1
            20   15  21 1
            21   16  22 1
            22   18  23 2
            23   20  24 1
            24   22  25 1
            25   23  26 1
            26   24  27 1
            27   27  28 1
            28   28  29 1
            29   28  30 2
            30   29  31 1
            31   30  32 1
            32   31  33 1
            33   32  34 1
            34   33  35 2
            35   34  36 2
            36    8  11 1
            37   19  23 1
            38   31  32 2
            39   35  36 1
///
